NSPR

InspireMD Inc

NSPR, USA

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for transcarotid access and neuro protection, as well as treating acute stroke with tandem lesions. It has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Miami, Florida.

https://www.inspiremd.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
NSPR
stock
NSPR

Aug Final Week: How Edison International(A3KYWK) stock behaves under inflation pressure - July 2025 Momentum & Reliable Entry Point Alerts moha.gov.vn

Read more →
NSPR
stock
NSPR

Can Tivoli A S 6YE stock withstand sector downturns - July 2025 Highlights & Accurate Entry and Exit Point Alerts moha.gov.vn

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$4.5

Analyst Picks

Strong Buy

1

Buy

1

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

High

2.21

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-19.82 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-16.19 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-355.21 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.22

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 39.46% of the total shares of InspireMD Inc

1.

Nantahala Capital Management, LLC

(5.556%)

since

2025/06/30

2.

Rosalind Advisors, Inc.

(5.4867%)

since

2025/06/30

3.

Orbimed Advisors, LLC

(5.1135%)

since

2025/06/30

4.

Soleus Capital Management, L.P.

(4.521%)

since

2025/06/30

5.

Marshall Wace Asset Management Ltd

(4.4592%)

since

2025/06/30

6.

Parkman Healthcare Partners LLC

(2.9609%)

since

2025/06/30

7.

abrdn Healthcare Investors

(2.9241%)

since

2025/08/31

8.

Velan Capital Investment Management LP

(2.1669%)

since

2025/06/30

9.

abrdn Healthcare Opportunities

(1.9418%)

since

2025/07/31

10.

abrdn World Healthcare

(1.0811%)

since

2025/07/31

11.

PURA VIDA INVESTMENTS, LLC

(1.0798%)

since

2025/06/30

12.

Affiance Financial LLC

(0.4533%)

since

2025/06/30

13.

UBS Group AG

(0.2987%)

since

2025/06/30

14.

Huntleigh Advisors Inc

(0.2978%)

since

2025/06/30

15.

Morgan Stanley - Brokerage Accounts

(0.2256%)

since

2025/06/30

16.

Ironwood Investment Management LLC

(0.1451%)

since

2025/06/30

17.

iShares Micro-Cap ETF

(0.1124%)

since

2025/08/31

18.

Northern Trust Corp

(0.1086%)

since

2025/06/30

19.

Schonfeld Strategic Advisors LLC

(0.0899%)

since

2025/06/30

20.

BlackRock Inc

(0.0877%)

since

2025/06/30

21.

Mesirow Fin Investmt Mgmt Intl Equity

(0.0719%)

since

2025/06/30

22.

Courier Capital Corp

(0.0719%)

since

2025/06/30

23.

Citadel Advisors Llc

(0.0627%)

since

2025/06/30

24.

Hollencrest Securities, LLC

(0.0479%)

since

2025/06/30

25.

Fidelity Nasdaq Composite Index

(0.0437%)

since

2025/07/31

26.

Essex Inv Mgt Micro Cap Growth

(0.0405%)

since

2025/03/31

27.

1290 VT Micro Cap K

(0.0092%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.19

Latest Release

Date

2025-09-30

EPS Actual

-0.17

EPS Estimate

-0.25

EPS Difference

0.08

Surprise Percent

32%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.3)
GARP
Fair GARP(4.5)
Growth
Weak Growth Prospect(3)
Momentum
No Momentum(2.5)
Net Net
Possible Net-Net(3.5)
Quality
Low Quality Business(3)
Value
Fair Value(6)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.